Date/Time:
Wednesday, December 16, 2020
4:30 PM – 5:30 PM EDT
Description:
The diagnosis and treatment of lymphomas and CLL have evolved tremendously over the past 15 years, particularly with the introduction of more effective and less toxic targeted therapies and immunotherapies. Within the last couple of years especially, the CLL treatment landscape in Canada has exploded. With so many developments in the CLL treatment spectrum over a short time, it is essential to provide patients with current information about their treatment options. This educational event will provide the Canadian CLL community with up-to-date information on:
- Overview of CLL diagnosis
- Why treatment may not always be recommended immediately after diagnosis
- Current front-line treatment options
- Current treatment options for relapsed/refractory CLL
- Emerging therapies for front-line and R/R CLL
Speaker:
Dr. Versha Banerji
Hematologist, CancerCare Manitoba
Assistant Professor, University of Manitoba Baker Cancer Centre
Dr. Versha Banerji obtained her undergraduate degree and clinical training in medicine and hematology from The University of Manitoba. She completed additional training in translational research at the Dana-Farber Cancer Centre and the Broad Institute of Harvard and MIT. She is the co-Lead of the CLL Clinic at CancerCare Manitoba/University of Manitoba. Dr. Banerji is a principal investigator for lymphoma clinical trials and has a focus on the diagnosis, prognosis and treatment of CLL.
